2-(4-(trifluoromethyl)cyclohexylidene)-N-((3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide

ID: ALA3804924

PubChem CID: 127048547

Max Phase: Preclinical

Molecular Formula: C15H22F3NO6

Molecular Weight: 369.34

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(C=C1CCC(C(F)(F)F)CC1)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C15H22F3NO6/c16-15(17,18)8-3-1-7(2-4-8)5-10(21)19-11-13(23)12(22)9(6-20)25-14(11)24/h5,8-9,11-14,20,22-24H,1-4,6H2,(H,19,21)/b7-5-/t8?,9-,11-,12-,13-,14?/m1/s1

Standard InChI Key:  QQPRUPZUZCUVJV-FZUIHZDBSA-N

Molfile:  

     RDKit          2D

 25 26  0  0  0  0  0  0  0  0999 V2000
    2.3383   -1.3500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0031   -3.0008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3039   -3.7494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3421   -3.1476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3070   -5.2502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6078   -5.9988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9074   -5.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2059   -6.0004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2050   -7.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9055   -8.2496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6069   -7.4988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5043   -8.2517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5443   -7.6529    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -6.5032   -9.4517    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5429   -8.8528    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3383   -1.3500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3383    1.3500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0031    3.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0432    3.5994    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  6  5  1  0
  7  6  1  0
  2  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 12 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
  6 22  1  1
  5 23  1  6
  4 24  1  1
 25 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3804924

    ---

Associated Targets(Human)

HK1 Tchem Hexokinase type I (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HK2 Tchem Hexokinase type II (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.34Molecular Weight (Monoisotopic): 369.1399AlogP: -0.42#Rotatable Bonds: 3
Polar Surface Area: 119.25Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 11.64CX Basic pKa: CX LogP: -0.40CX LogD: -0.40
Aromatic Rings: Heavy Atoms: 25QED Weighted: 0.43Np Likeness Score: 1.06

References

1. Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI..  (2016)  Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors.,  (3): [PMID:26985301] [10.1021/acsmedchemlett.5b00214]

Source